A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desens...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Jaime S. Rosa, Van B. Vuong, Orly Haskin and Anne Y. Liu Tags: Case report Source Type: research
More News: Allergy | Allergy & Immunology | Anemia | Aranesp | Asthma | Epogen | Pediatrics | Procrit | Renal Failure